Clinical Trial

Impact of a Glaucoma Awareness Program on Treatment Adherence

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Glaucoma is a leading cause of irreversible blindness worldwide, with a higher burden in low- and middle-income countries such as Nepal, where public awareness and treatment adherence remain poor. Lifelong adherence to treatment is important to prevent disease progression but still non adherence remains common. This is a mixed method study which aims to evaluate the effectiveness of structured glaucoma awareness program in improving treatment adherence among glaucoma patients attending a tertiary eye hospital in Nepal. Quantitative assessment will measure changes in treatment adherence using Medication Adherence Scale at baseline and three months post intervention. A qualitative component will explore participants' perceptions of glaucoma program and suggestions for improvement through semi-structured interviews.
Trial Details
NCT Number NCT07488234
Lead Sponsor Seva Canada Society
Collaborators: Reiyukai Eiko Masunaga Eye Hospital (REMEH), Pragyaan Sustainable Health Outcomes Foundation
Conditions Glaucoma
Enrollment 60 participants
Start Date 2026-04
Primary Completion 2027-04 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-23